Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway

Objective: DUSP6 is a negative regulator of the ERK signaling pathway and plays an important role in chemotherapy-resistance. Previously we showed that DUSP6 is overexpressed in ovarian cancer side population (SP) cells that possess cancer stem cell-like properties and are quiescent and chemotherapy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Gao, Yan, Li, Hui, Han, Qing, Li, Yuan, Wang, Tongxia, Huang, Cuiyu, Mao, Yiqing, Wang, Xi, Zhang, Qun, Tian, Junrui, Irwin, David M., Tan, Huanran, Guo, Hongyan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2020
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7097933/
https://ncbi.nlm.nih.gov/pubmed/32231719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.37267
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak